{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARs", "analgesic", "anti-inflammatory", "anticancer", "benzopyrazole", "indazole", "tautomers"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35971890", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "25"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1002/ddr.21979"], "Journal": {"ISSN": "1098-2299", "JournalIssue": {"Volume": "83", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Nov"}}, "Title": "Drug development research", "ISOAbbreviation": "Drug Dev Res"}, "ArticleTitle": "A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective.", "Pagination": {"StartPage": "1469", "EndPage": "1504", "MedlinePgn": "1469-1504"}, "Abstract": {"AbstractText": ["With different nitrogen-containing heterocyclic moieties, Indazoles earn one of the places among the top investigated molecules in medicinal research. Indazole, an important fused aromatic heterocyclic system containing benzene and pyrazole ring with a chemical formula of C<sub>7</sub> H<sub>6</sub> N<sub>2</sub> , is also called benzopyrazole. Indazoles consist of three tautomeric forms in which 1H-tautomers (indazoles) and 2H-tautomers (isoindazoles) exist in all phases. The tautomerism in indazoles greatly influences synthesis, reactivity, physical and even the biological properties of indazoles. The thermodynamic internal energy calculation of these tautomers points view 1H-indazole as the predominant and stable form over 2H-indazole. The natural source of indazole is limited and exists in alkaloidal nature (i.e., nigellidine, nigeglanine, nigellicine, etc.) found from Nigella plants. Some of the FDA-approved drugs like Axitinib, Entrectinib, Niraparib, Benzydamine, and Granisetron are being used to treat renal cell cancer, non-small cell lung cancer (NSCLC), epithelial ovarian cancer, chronic inflammation, chemotherapy-induced nausea, vomiting, and many more uses. Besides all these advantages regarding its biological activity, the main issue about indazoles is the less abundance in plant sources, and their synthetic derivatives also often face problems with low yield. In this review article, we discuss its chemistry, tautomerism along with their effects, different schematics for the synthesis of indazole derivatives, and their different biological activities."], "CopyrightInformation": "\u00a9 2022 Wiley Periodicals LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Siksha 'O' Anusandhan University (Deemed to be University), Bhubaneswar, Odisha, India."}], "LastName": "Mal", "ForeName": "Suvadeep", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, Chhattisgarh, India."}], "LastName": "Malik", "ForeName": "Udita", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Siksha 'O' Anusandhan University (Deemed to be University), Bhubaneswar, Odisha, India."}], "LastName": "Mahapatra", "ForeName": "Monalisa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Aurobindo Pharma, Morrisville, Durham, North Carolina, USA."}], "LastName": "Mishra", "ForeName": "Abhishek", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, Chhattisgarh, India."}], "LastName": "Pal", "ForeName": "Dilipkumar", "Initials": "D"}, {"Identifier": ["0000-0003-1210-2293"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Siksha 'O' Anusandhan University (Deemed to be University), Bhubaneswar, Odisha, India."}], "LastName": "Paidesetty", "ForeName": "Sudhir K", "Initials": "SK"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Drug Dev Res", "NlmUniqueID": "8204468", "ISSNLinking": "0272-4391"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Indazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Carcinoma, Non-Small-Cell Lung"}, {"QualifierName": [], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Indazoles"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antineoplastic Agents"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Aanandhi, M. V., Joseph, A. A., Chandrakumar, R., Koilraj, M., Sujatha, R., & Shanmugasundaram, P. (2016). Synthesis and biological activities of a novel series of indazole derivatives. Biosciences Biotechnology Research Asia, 5, 313-318."}, {"Citation": "Abbassi, N., Rakib, E. M., Chicha, H., Bouissane, L., Hannioui, A., Aiello, C., Gangemi, R., Castagnola, P., Rosano, C., & Viale, M. (2014). Synthesis and antitumor activity of some substituted indazole derivatives. Archiv der Pharmazie, 347, 423-431. https://doi.org/10.1002/ardp.201300390"}, {"Citation": "Abed, H. B., Schoene, J., Christmann, M., & Nazar\u00e9, M. (2016). Organophosphorus-mediated N-N bond formation: Facile access to 3-amino-2 H-indazoles. Organic and Biomolecular Chemistry, 14, 8520-8528. https://doi.org/10.1039/C6OB01544A"}, {"Citation": "Abouzid, K. A., & El-Abhar, H. S. (2003). Synthesis and antiinflammatory activity of novel indazolones. Archives of Pharmacal Research, 26, 1-8. https://doi.org/10.1007/bf03179922"}, {"Citation": "Aghazadeh Tabrizi, M., Baraldi, P. G., Baraldi, S., Gessi, S., Merighi, S., & Borea, P. A. (2017). Medicinal chemistry, pharmacology, and clinical implications of TRPV1 receptor antagonists. Medicinal Research Reviews, 37, 936-983. https://doi.org/10.1002/med.21427"}, {"Citation": "Akay, M., Funingana, I. G., Patel, G., Mustapha, R., Gjafa, E., Ng, T., Ng, K., & Flynn, M. J. (2021). An in-depth review of niraparib in ovarian cancer: Mechanism of action, clinical efficacy and future directions. Oncology\u00a0and Therapy, 9, 347-364. https://doi.org/10.1007/s40487-021-00167-z"}, {"Citation": "Ali, Z., Ferreira, D., Carvalho, P., Avery, M. A., & Khan, I. A. (2008). Nigellidine-4-O-sulfite, the first sulfated indazole-type alkaloid from the seeds of Nigella sativa. Journal of Natural Products, 71, 1111-1112. https://doi.org/10.1021/np800172x"}, {"Citation": "Andorsky, D. J., Kolibaba, K. S., Assouline, S., Forero-Torres, A., Jones, V., Klein, L. M., Patel-Donnelly, D., Smith, M., Ye, W., Shi, W., & Yasenchak, C. A. (2019). An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma. British Journal of Haematology, 184, 215-222. https://doi.org/10.1111/bjh.15552"}, {"Citation": "Ar\u00e1n, V. J., Stud, M., Foces-Foces, C., Cano, F. H., & Mart\u00ednez-Ripoll, M. (1985). Synthesis of indazole derivatives from a N, N-disubstituted 2-halobenzoic hydrazide. Crystal structure of 1, 2-pentamethylene-5-nitro-1, 2-dihydro-3H-indazol-3-one. Journal of Heterocyclic Chemistry, 22, 1743-1745. https://doi.org/10.1002/jhet.5570220655"}, {"Citation": "Ardini, E., Menichincheri, M., Banfi, P., Bosotti, R., De Ponti, C., Pulci, R., Ballinari, D., Ciomei, M., Texido, G., Degrassi, A., & Avanzi, N. (2016). Entrectinib, a Pan-TRK, ROS1, and ALK inhibitor with activity in multiple molecularly defined cancer indications. Molecular Cancer Therapeutics, 15, 628-639. https://doi.org/10.1158/1535-7163.MCT-15-0758"}, {"Citation": "Arrouchi, H., Lakhlili, W., & Ibrahimi, A. (2019). A review on PIM kinases in tumors. Bioinformation, 15, 40-45. https://doi.org/10.6026/97320630015040"}, {"Citation": "Atta-UR-Rahman, A. U., Malik, S., Hasan, S. S., Choudhary, M. I., Ni, C. Z., & Clardy, J. (1995). Nigellidine-A new indazole alkaloid from the seeds of Nigella sativa. ChemInform, 26, 30."}, {"Citation": "Baddam, S. R., Kumar, N. U., Reddy, A. P., & Bandichhor, R. (2013). Regioselective methylation of indazoles using methyl 2, 2, 2-trichloromethylacetimidate. Tetrahedron Letters, 54, 1661-1663. https://doi.org/10.1016/j.tetlet.2013.01.030"}, {"Citation": "Balfour, J. A., & Clissold, S. P. (1990). Bendazac lysine. Drugs, 39, 575-596. https://doi.org/10.2165/00003495-199039040-00007"}, {"Citation": "Banerjee, T., Aggarwal, M., Sommers, J. A., Brosh, R. M., Jr. (2016). Biochemical and cell biological assays to identify and characterize DNA helicase inhibitors. Methods, 108, 130-141. https://doi.org/10.1016/j.ymeth.2016.04.007"}, {"Citation": "Batt, D. G., Petraitis, J. J., Houghton, G. C., Modi, D. P., Cain, G. A., Corjay, M. H., Mousa, S. A., Bouchard, P. J., Forsythe, M. S., Harlow, P. P., & Barbera, F. A. (2000). Disubstituted indazoles as potent antagonists of the integrin \u03b1v\u03b23. Journal of Medicinal Chemistry, 43, 41-58. https://doi.org/10.1021/jm990049j"}, {"Citation": "Bellesoeur, A., Carton, E., Alexandre, J., Goldwasser, F., & Huillard, O. (2017). Axitinib in the treatment of renal cell carcinoma: Design, development, and place in therapy. Drug Design, Development and Therapy, 11, 2801-2811. https://doi.org/10.2147/dddt.s109640"}, {"Citation": "Bharali, P., Tina, M., Mahanta, D., Kalita, M. C., & Das, A. K. (2019). Phytoconstituent evaluation of Pyrus pashia Buch.-Ham. ex D. Don-A potential ethnomedicinal plant from Arunachal Pradesh, India. Current Science, 113(7), 1434-1439. https://doi.org/10.26679/Pleione.13.2.2019.284-290"}, {"Citation": "Billio, A., Morello, E., & Clarke, M. J. (2010). Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database of Systematic Reviews, (1), CD006272. https://doi.org/10.1002/14651858.cd006272.pub2"}, {"Citation": "Buchanan, D., & Muirhead, K. (2007). Use Intractable nausea and vomiting successfully related with granisetron 5-hydroxtrytamine type 3 receptor antagonists in Palliative Medicine. Palliative Medicine, 21, 725-726. https://doi.org/10.1177/0269216307083383"}, {"Citation": "Cahn, A., Hamblin, J. N., Robertson, J., Begg, M., Jarvis, E., Wilson, R., Dear, G., Leemereise, C., Cui, Y., Mizuma, M., & Montembault, M. (2021). An inhaled PI3K\u03b4 inhibitor improves recovery in acutely exacerbating COPD patients: A randomized trial. International Journal of Chronic Obstructive Pulmonary Disease, 16, 1607. https://doi.org/10.2147/copd.s309129"}, {"Citation": "Cai, S., Lin, S., Yi, X., & Xi, C. (2017). Substrate-controlled transformation of azobenzenes to indazoles and indoles via rh (III)-catalysis. Journal of Organic Chemistry, 82, 512-520. https://doi.org/10.1021/acs.joc.6b02548"}, {"Citation": "Cao, Y., Luo, C., Yang, P., Li, P., & Wu, C. (2021). Indazole scaffold: A generalist for marketed and clinical drugs. Medicinal Chemistry Research, 30, 501-518. https://doi.org/10.1007/s00044-020-02665-7"}, {"Citation": "Catalan, J., & Elguero, J. (1987). Basicity and acidity of azoles. Advances in Heterocyclic Chemistry, 41, 187-274. https://doi.org/10.1016/S0065-2725(08)60162-2"}, {"Citation": "Catalan, J., del Valle, J. C., Claramunt, R. M., Boyer, G., Laynez, J., Gomez, J., Jimenez, P., Tomas, F., & Elguero, J. (1994). Acidity and basicity of indazole and its N-methyl derivatives in the ground and in the excited state. Journal of Physical Chemistry, 98, 10606-10612. https://doi.org/10.1021/j100092a035"}, {"Citation": "Catal\u00e1n, J., de Paz, J. L., & Elguero, J. (1996). Importance of aromaticity on the relative stabilities of indazole annular tautomers: An ab initio study. Journal of the Chemical Society, Perkin Transactions, 2, 57-60. https://doi.org/10.1039/P29960000057"}, {"Citation": "Cazzola, M., Coppola, A., Rogliani, P., & Matera, M. G. (2015). Novel glucocorticoid receptor agonists in the treatment of asthma. Expert Opinion on Investigational Drugs, 24, 1473-1482. https://doi.org/10.1517/13543784.2015.1078310"}, {"Citation": "Chabukswar, A., Kuchekar, B., Lokhande, P., Tryambake, M., Pagare, B., Kadam, V., Jagdale, S., & Chabukswar, V. (2013). Design, synthesis and evaluation of antibacterial activity of novel indazole derivatives. Current Bioactive Compounds, 9, 263-269."}, {"Citation": "Chamakuri, K., Muppavarapu, S. M., & Yellu, N. R. (2016). Synthesis and analgesic and anti-inflammatory activities of 7-azaindazole chalcone derivatives. Medicinal Chemistry Research, 25(10), 2392-2398. https://doi.org/10.1007/s00044-016-1671-2"}, {"Citation": "Chamberlain, F. E., Wilding, C., Jones, R. L., & Huang, P. (2019). Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. Expert Opinion on Investigational Drugs, 28, 505-511. https://doi.org/10.1080/13543784.2019.1607291"}, {"Citation": "Cheekavolu, C., & Muniappan, M. (2016). In vivo and in vitro anti-inflammatory activity of indazole and its derivatives. Journal of Clinical and Diagnostic Research, 10, FF01. https://doi.org/10.7860/jcdr/2016/19338.8465"}, {"Citation": "Chen, C. Y., Tang, G., He, F., Wang, Z., Jing, H., & Faessler, R. (2016). A synthesis of 1 H-Indazoles via a Cu (OAc) 2-catalyzed N-N bond formation. Organic Letters, 18, 1690-1693. https://doi.org/10.1021/acs.orglett.6b00611"}, {"Citation": "Chen, G., Hu, M., & Peng, Y. (2018). Switchable synthesis of 3-Substituted 1 H-Indazoles and 3, 3-Disubstituted 3 H-Indazole-3-phosphonates tuned by phosphoryl groups. Journal of Organic Chemistry, 83, 1591-1597.\u00a0https://doi.org/10.1021/acs.joc.7b02857"}, {"Citation": "Chen, Y. (2019). Progress in research on protein tyrosine kinase inhibitors. AIP Conference Proceedings, 2058, 020006. https://doi.org/10.1063/1.5085519"}, {"Citation": "Chen, Y., Tortorici, M. A., Garrett, M., Hee, B., Klamerus, K. J., Pithavala, Y. K. (2013). Clinical pharmacology of axitinib. Clinical Pharmacokinetics, 52, 713-725. https://doi.org/10.1007/s40262-013-0068-3"}, {"Citation": "Cheptea, C., \u0218unel, V., Stan, C., & Dorohoi, D. O. (2012). New derivatives of 5-nitro-indazole with potential antitumor activity. Revue Roumaine de Chimie, 57, 229."}, {"Citation": "Cheruvallath, Z. S., Gwaltney, S. L., II, Sabat, M., Tang, M., Wang, H., Jennings, A., Hosfield, D., Lee, B., Wu, Y., Halkowycz, P., & Grimshaw, C. E. (2017). Discovery of potent and orally active 1, 4-disubstituted indazoles as novel allosteric glucokinase activators. Bioorganic & Medicinal Chemistry Letters, 27, 2678-2682. https://doi.org/10.1016/j.bmcl.2017.04.041"}, {"Citation": "Chu, Y. Y., Cheng, H. J., Tian, Z. H., Zhao, J. C., Li, G., Chu, Y. Y., Sun, C. J., & Li, W. B. (2017). Rational drug design of indazole-based diarylurea derivatives as anticancer agents. Chemical Biology & Drug Design, 90, 609-617. https://doi.org/10.1111/cbdd.12984"}, {"Citation": "Counceller, C. M., Eichman, C. C., Wray, B. C., & Stambuli, J. P. (2008). A practical, metal-free synthesis of 1 H-indazoles. Organic Letters, 10, 1021-1023. https://doi.org/10.1021/ol800053f"}, {"Citation": "Crestey, F., Collot, V., Stiebing, S., Lohier, J. F., Sopkova-de Oliveira Santos, J., & Rault, S. (2007). New practical access to 2-azatryptophans and dehydro derivatives via the Wittig-Horner reaction. Tetrahedron Letters, 48, 2457-2460. https://doi.org/10.1016/j.tetlet.2007.02.042"}, {"Citation": "Cui, J., Peng, X., Gao, D., Dai, Y., Ai, J., & Li, Y. (2017). Optimization of 1H-indazol-3-amine derivatives as potent fibroblast growth factor receptor inhibitors. Bioorganic & Medicinal Chemistry Letters, 27, 3782-3786. https://doi.org/10.1016/j.bmcl.2017.06.068"}, {"Citation": "Cui, Y. J., Ma, C. C., Zhang, C. M., Tang, L. Q., & Liu, Z. P. (2020). The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo. European Journal of Medicinal Chemistry, 187, 111968. https://doi.org/10.1016/j.ejmech.2019.111968"}, {"Citation": "Cyr, P., Regnier, S., Bechara, W. S., & Charette, A. B. (2015). Rapid access to 3-aminoindazoles from tertiary amides. Organic Letters, 17, 3386-2289. https://doi.org/10.1021/acs.orglett.5b00765"}, {"Citation": "Denis, C., Sopkov\u00e1-de Oliveira Santos, J., Bureau, R., & Voisin-Chiret, A. S. (2019). Hot-Spots of Mcl-1 protein: Miniperspective. Journal of Medicinal Chemistry, 63, 928-943. https://doi.org/10.1021/acs.jmedchem.9b00983"}, {"Citation": "Dimmito, M. P., Stefanucci, A., Pieretti, S., Minosi, P., Dvor\u00e1csk\u00f3, S., T\u00f6mb\u00f6ly, C., Zengin, G., & Mollica, A. (2019). Discovery of orexant and anorexant agents with indazole scaffold endowed with peripheral antiedema activity. Biomolecules, 9, 492. https://doi.org/10.3390/biom9090492"}, {"Citation": "Ditonno, P., Battaglia, M., Selvaggio, O., Garofalo, L., Lorusso, V., & Selvaggi, F. P. (2005). Clinical evidence supporting the role of lonidamine for the treatment of BPH. Reviews in urology, 7, S27-S33."}, {"Citation": "Dong, J., Zhang, Q., Wang, Z., Huang, G., & Li, S. (2018). Recent advances in the development of indazole-based anticancer agents. Chem Med Chem, 13, 1490-1507. https://doi.org/10.1002/cmdc.201800253"}, {"Citation": "Down, K., Amour, A., Baldwin, I. R., Cooper, A. W., Deakin, A. M., Felton, L. M., Guntrip, S. B., Hardy, C., Harrison, Z. A., Jones, K. L., & Jones, P. (2015). Optimization of novel indazoles as highly potent and selective inhibitors of phosphoinositide 3-kinase \u03b4 for the treatment of respiratory disease. Journal of Medicinal Chemistry, 58, 7381-7399. https://doi.org/10.1021/acs.jmedchem.5b00767"}, {"Citation": "Drilon, A. (2019). TRK inhibitors in TRK fusion-positive cancers. Annals of Oncology, 30, 23-30. https://doi.org/10.1093/annonc/mdz282"}, {"Citation": "Du, S., Lu, H., Yang, D., Li, H., Gu, X., Wan, C., Jia, C., Wang, M., Li, X., & Qin, Z. (2015). Synthesis, antifungal activity and QSAR of some novel carboxylic acid amides. Molecules, 20, 4071-4087. https://doi.org/10.3390/molecules20034071"}, {"Citation": "El Aali, N. M. (2018). GC/mass analysis of Adiantium capillus veneris Linn. Acta Scientific Microbiology, 1, 30-44."}, {"Citation": "Elguero, J., Alkorta, I., Claramunt, R. M., Cabildo, P., Cornago, P., Farr\u00e1n, M., Garc\u00eda, M., L\u00f3pez, C., P\u00e9rez-Torralba, M., Mar\u00eda, D. S., & Sanz, D. (2013). Structure of NH-benzazoles (1H-benzimidazoles, 1H-and 2H-indazoles, 1H-and 2H-benzotriazoles). Chemistry of Heterocyclic Compounds, 49, 177-202. https://doi.org/10.1007/s10593-013-1237-x"}, {"Citation": "El-Hawash, S. A., Badawey, E. S., & El-Ashmawey, I. M. (2006). Nonsteroidal antiinflammatory agents-part 2 antiinflammatory, analgesic and antipyretic activity of some substituted 3-pyrazolin-5-ones and 1, 2, 4, 5, 6, 7-3H-hexahydroindazol-3-ones. European Journal of Medicinal Chemistry, 41, 155-165. https://doi.org/10.1016/j.ejmech.2005.09.006"}, {"Citation": "Elsayed, N. M., Abou El Ella, D. A., Serya, R. A., Tolba, M. F., Shalaby, R., & Abouzid, K. A. (2016). Design, synthesis and biological evaluation of indazole-pyrimidine based derivatives as anticancer agents with anti-angiogenic and antiproliferative activities. MedChemComm, 7(5), 881-899. https://doi.org/10.1039/C5MD00602C"}, {"Citation": "Evans, T. C., Levy, B. R., & Szabocsik JO, J. O. (1993). Clinical study of bendazac lysine for in vivo contact lens cleaning. Optometry and Vision Science, 70, 210-215. https://doi.org/10.1097/00006324-199303000-00007"}, {"Citation": "Fahy, W., Homayoun-Valiani, F., Cahn, A., Robertson, J., Templeton, A., Meeraus, W., Wilson, R., Lowings, M., Marotti, M., Tabberer, M., & West, S. (2019). Nemiralisib in patients experiencing an acute exacerbation of COPD: Design of a double-blind, randomized, placebo-controlled, dose-ranging phase IIb study, C32. COPD: Translational and mechanistic studies (p. A4523). American Thoracic Society."}, {"Citation": "Fanaki, N. H., & El-Nakeeb, M. A. (1992). Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent. Journal of Chemotherapy, 4, 347-352. https://doi.org/10.1080/1120009x.1992.11739190"}, {"Citation": "Farooqi, A. A., & Siddik, Z. H. (2015). Platelet-derived growth factor (PDGF) signalling in cancer: Rapidly emerging signalling landscape. Cell Biochemistry and Function, 33, 257-265. https://doi.org/10.1002/cbf.3120"}, {"Citation": "Farooqui, M., Ali, N. A., Zaheer, Z., Rahman, Z. U., & Khan, A. (2010). Synthesis, anti-bacterial, analgesic and anti-inflammatory activities of some new biologically important indazole derivatives. International Journal of Drug Design & Discovery, 1, 314-324."}, {"Citation": "Ferguson, H. R., Smith, M. P., & Francavilla, C. (2021). Fibroblast growth factor receptors (FGFRs) and noncanonical partners in cancer signaling. Cells, 10, 1201. https://doi.org/10.3390/cells10051201"}, {"Citation": "Gaikwad, D. D., Abed, S., & Pawar, R. P. (2009). Molecular iodine as an efficient catalyst for the synthesis of indazole. International Journal of ChemTech Research, 1, 442-445."}, {"Citation": "Gaikwad, D. D., Chapolikar, A. D., Devkate, C. G., Warad, K. D., Tayade, A. P., Pawar, R. P., & Domb, A. J. (2015). Synthesis of indazole motifs and their medicinal importance: An overview. European Journal of Medicinal Chemistry, 90, 707-731. https://doi.org/10.1016/j.ejmech.2014.11.029"}, {"Citation": "Ge, Y., Zhang, Y., Li, X., Yu, Y., & Liu, Q. (2019). Pharmacokinetics and metabolism of H3B-6545, a selective estrogen receptor covalent antagonist, in dog plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 172, 189-199. https://doi.org/10.1016/j.jpba.2019.04.045"}, {"Citation": "Gein, V. L., Yankin, A. N., Nosova, N. V., Levandovskaya, E. B., Novikova, V. V., & Rudakova, I. P. (2019). Synthesis and biological activity of 4, 5, 6, 7-tetrahydro-2H-indazole derivatives. Russian Journal of General Chemistry, 89, 1169-1176."}, {"Citation": "Gerpe, A., Aguirre, G., Boiani, L., Cerecetto, H., Gonz\u00e1lez, M., Olea-Azar, C., Rigol, C., Maya, J. D., Morello, A., Piro, O. E., & Ar\u00e1n, V. J. (2006). Indazole N-oxide derivatives as antiprotozoal agents: Synthesis, biological evaluation and mechanism of action studies. Bioorganic and Medicinal Chemistry, 14, 3467-3480. https://doi.org/10.1016/j.bmc.2006.01.007"}, {"Citation": "Giannouli, V., Kostakis, I. K., Pouli, N., Marakos, P., Kousidou, O. C., Tzanakakis, G. N., & Karamanos, N. K. (2007). Design synthesis, and evaluation of the antiproliferative activity of a series of novel fused xanthenone amino derivatives in human breast cancer cells. Journal of Medicinal Chemistry, 50, 1716-1719. https://doi.org/10.1021/jm061410m"}, {"Citation": "Goodyear, A., Linghu, X., Bishop, B., Chen, C., Cleator, E., McLaughlin, M., Sheen, F. J., Stewart, G. W., Xu, Y., & Yin, J. (2012). Process development and large-scale synthesis of MK-6186, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV. Organic Process Research & Development, 16, 605-611. https://doi.org/10.1021/op200334x"}, {"Citation": "Gross-Goupil, M., Fran\u00e7lois, L., Quivy, A., & Ravaud, A. (2013). Axitinib: A review of its safety and efficacy in the treatment of adults with advanced renal cell carcinoma. Clinical Medicine Insights: Oncology, 7, S10594. https://doi.org/10.4137/cmo.s10594"}, {"Citation": "Haile, P. A., Votta, B. J., Marquis, R. W., Bury, M. J., Mehlmann, J. F., Singhaus, R., Jr., Charnley, A. K., Lakdawala, A. S., Convery, M. A., Lipshutz, D. B., & Desai, B. M. (2016). The identification and pharmacological characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1 H-indazol-3-yl) quinolin-4-amine (GSK583), a highly potent and selective inhibitor of RIP2 kinase. Journal of Medicinal Chemistry, 59, 4867-4880. https://doi.org/10.1021/acs.jmedchem.6b00211"}, {"Citation": "Hari, Y., Shoji, Y., & Aoyama, T. (2005). Regioselective synthesis of 1-arylindazoles via N-arylation of 3-trimethylsilylindazoles. Tetrahedron Letters, 46, 3771-3774. https://doi.org/10.1016/j.tetlet.2005.03.157"}, {"Citation": "Hari, Y., Sone, R., & Aoyama, T. (2009). Facile two-step synthesis of 3-substituted indazoles using diazo (trimethylsilyl) methylmagnesium bromide. Organic and Biomolecular Chemistry, 7, 2804-2808. https://doi.org/10.1039/B907796K"}, {"Citation": "Harris, P. A., Boloor, A., Cheung, M., Kumar, R., Crosby, R. M., Davis-Ward, R. G., Epperly, A. H., Hinkle, K. W., Hunter, R. N., III, Johnson, J. H., & Knick, V. B. (2008). Discovery of 5-[[4-[(2, 3-dimethyl-2 H-indazol-6-yl) methylamino]-2-pyrimidinyl] amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor. Journal of Medicinal Chemistry, 51, 4632-4640. https://doi.org/10.1021/jm800566m"}, {"Citation": "Hase, G. J., Deshmukh, K. K., Pokharkar, R. D., Gaje, T. R., & Phatanagre, N. D. (2017). Phytochemical studies on Nerium oleander L. using GC-MS. International Journal of Pharmacognosy and Phytochemical Research, 9, 885-891. https://doi.org/10.25258/phyto.v9i6.8195"}, {"Citation": "Hemmerling, M., Edman, K., Lepist\u00f6, M., Eriksson, A., Ivanova, S., Dahm\u00e9n, J., Rehwinkel, H., Berger, M., Hendrickx, R., Dearman, M., & Jensen, T. J. (2016). Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators. Bioorganic & Medicinal Chemistry Letters, 26, 5741-5748. https://doi.org/10.1016/j.bmcl.2016.10.052"}, {"Citation": "Henley, Z. A., Bax, B. D., Inglesby, L. M., Champigny, A., Gaines, S., Faulder, P., Le, J., Thomas, D. A., Washio, Y., & Baldwin, I. R. (2017). From PIM1 to PI3K\u03b4 via GSK3\u03b2: Target hopping through the Kinome. ACS Medicinal Chemistry Letters, 8, 1093-1098. https://doi.org/10.1021/acsmedchemlett.7b00296"}, {"Citation": "Hodos\u0306\u0115k, M., Kocjan, D., & Hadzi, D. (1988). Ab initio calculations on the hydration of dimethylpyrazole and indazole. Solvent effects on tautomeric energies. Journal of Molecular Structure: THEOCHEM, 165, 115-124. https://doi.org/10.1016/0166-1280(88)87010-6"}, {"Citation": "Honore, P., Chandran, P., Hernandez, G., Gauvin, D. M., Mikusa, J. P., Zhong, C., Joshi, S. K., Ghilardi, J. R., Sevcik, M. A., Fryer, R. M., & Segreti, J. A. (2009). Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain, 142, 27-35. https://doi.org/10.1016/j.pain.2008.11.004"}, {"Citation": "Hoyt, S. B., Taylor, J., London, C., Ali, A., Ujjainwalla, F., Tata, J., Struthers, M., Cully, D., Wisniewski, T., Ren, N., & Bopp, C. (2017). Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension. Bioorganic & Medicinal Chemistry Letters, 27, 2384-2388. https://doi.org/10.1016/j.bmcl.2017.04.021"}, {"Citation": "Hu, J., Cheng, Y., Yang, Y., & Rao, Y. (2011). A general and efficient approach to 2 H-indazoles and 1 H-pyrazoles through copper-catalyzed intramolecular N-N bond formation under mild conditions. Chemical Communications, 47, 10133-10135. https://doi.org/10.1039/C1CC13908H"}, {"Citation": "Hu, W., Yu, J. T., Liu, S., Jiang, Y., & Cheng, J. (2017). Copper-mediated annulation of 2-(1-arylvinyl) anilines and aryl nitrosos towards 2, 3-diaryl-2 H-indazoles. Organic Chemistry Frontiers, 4, 22-25. https://doi.org/10.1039/C6QO00540C"}, {"Citation": "Hurst, R., Rollema, H., & Bertrand, D. (2013). Nicotinic acetylcholine receptors: From basic science to therapeutics. Pharmacology and Therapeutics, 137, 22-54. https://doi.org/10.1016/j.pharmthera.2012.08.012"}, {"Citation": "Ikeda, Y., Takano, N., Matsushita, H., Shiraki, Y., Koide, T., Nagashima, R., Fujimura, Y., Shindo, M., Suzuki, S., & Iwasaki, T. (1979). Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino) propyl]-5-methyl-3-phenyl-1H-indazole (FS-32). Arzeneimittel-Forschung, 29, 511-520."}, {"Citation": "Jagasia, M., Lazaryan, A., Bachier, C. R., Salhotra, A., Weisdorf, D. J., Zoghi, B., Essell, J., Green, L., Schueller, O., Patel, J., & Zanin-Zhorov, A. (2021). ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease. Journal of Clinical Oncology, 39, 1888-1898. https://doi.org/10.1200/JCO.20.02754"}, {"Citation": "Janardhanan, J. C., Mishra, R. K., Das, G., Sini, S., Jayamurthy, P., Suresh, C. H., Praveen, V. K., Manoj, N., & Babu, B. P. (2018). Functionalizable 1H-indazoles by palladium catalyzed aza-nenitzescu reaction: Pharmacophores to donor-acceptor type multi-luminescent fluorophores. Asian Journal of Organic Chemistry, 7, 2094-2104. https://doi.org/10.1002/ajoc.201800413"}, {"Citation": "Jeong, T., Han, S. H., Han, S., Sharma, S., Park, J., Lee, J. S., Kwak, J. H., Jung, Y. H., & Kim, I. S. (2016). Access\u00a0to 3-acyl-(2 H)-indazoles via Rh (III)-catalyzed C-H addition and cyclization of azobenzenes with \u03b1-keto aldehydes. Organic Letters, 18, 232-235. https://doi.org/10.1021/acs.orglett.5b03368"}, {"Citation": "Jones, P., Storer, R. I., Sabnis, Y. A., Wakenhut, F. M., Whitlock, G. A., England, K. S., Mukaiyama, T., Dehnhardt, C. M., Coe, J. W., Kortum, S. W., & Chrencik, J. E. (2017). Design and synthesis of a pan-Janus kinase inhibitor clinical candidate (PF-06263276) suitable for inhaled and topical delivery for the treatment of inflammatory diseases of the lungs and skin. Journal of Medicinal Chemistry, 60, 767-786. https://doi.org/10.1021/acs.jmedchem.6b01634"}, {"Citation": "Kang, J. M., Kwon, S. O., Ann, J., Blumberg, P. M., Ha, H., Yoo, Y. D., Frank-Foltyn, R., Lesch, B., Bahrenberg, G., Stockhausen, H., & Christoph, T. (2020). Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl) methyl) ureas as potent and thermoneutral TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters, 30, 127548. https://doi.org/10.1016/j.bmcl.2020.127548"}, {"Citation": "Kasper, B., & Hohenberger, P. (2011). Pazopanib: A promising new agent in the treatment of soft tissue sarcomas. Future Oncology, 7, 1373-13783. https://doi.org/10.2217/fon.11.116"}, {"Citation": "Kawakubo, H., Sone, T., Wakigawa, K., & Narita, T. (1987). Anti-inflammatory, analgesic properties and antipyretic action of 3-aminoindazole derivatives. Yakugaku Zasshi, 107, 28-36. https://doi.org/10.1248/yakushi1947.107.1_28"}, {"Citation": "Keisner, S. V., & Shah, S. R. (2011). Pazopanib. Drugs, 71, 443-454. https://doi.org/10.2165/11588960-000000000-00000"}, {"Citation": "Kerru, N., Gummidi, L., Maddila, S., Gangu, K. K., & Jonnalagadda, S. B. (2020). A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules, 25, 1909. https://doi.org/10.3390/molecules25081909"}, {"Citation": "Kim, H. T., Ha, H., Kang, G., Kim, O. S., Ryu, H., Biswas, A. K., Lim, S. M., Baik, M. H., & Joo, J. M. (2017). Ligand-controlled regiodivergent C\u2212H alkenylation of pyrazoles and its application to the synthesis of indazoles. Angewandte Chemie-International Edition in English, 56, 16262-16266. https://doi.org/10.1002/anie.201709162"}, {"Citation": "Kim, O. S., Jang, J. H., Kim, H. T., Han, S. J., Tsui, G. C., & Joo, J. M. (2017). Synthesis of fluorescent indazoles by palladium-catalyzed benzannulation of pyrazoles with alkynes. Organic Letters, 19, 1450-1453. https://doi.org/10.1021/acs.orglett.7b00410"}, {"Citation": "Kim, S. H., Markovitz, B., Trovato, R., Murphy, B. R., Austin, H., Willardsen, A. J., Baichwal, V., Morham, S., & Bajji, A. (2013). Discovery of a new HIV-1 inhibitor scaffold and synthesis of potential prodrugs of indazoles. Bioorganic & Medicinal Chemistry Letters, 23, 2888-2892. https://doi.org/10.1016/j.bmcl.2013.03.075"}, {"Citation": "Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. W. (2002). Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene, 285, 1-24. https://doi.org/10.1016/s0378-1119(02)00398-0"}, {"Citation": "Kleinman, H. K., Kim, K., & Kang, H. (2018). Matrigel uses in cell biology and for the identification of thymosin \u03b24, a mediator of tissue regeneration. Applied Biological Chemistry, 61, 703-708. https://doi.org/10.1007/s13765-018-0400-6"}, {"Citation": "Konicek, B. W., Capen, A. R., Credille, K. M., Ebert, P. J., Falcon, B. L., Heady, G. L., Patel, B. K., Peek, V. L., Stephens, J. R., Stewart, J. A., & Stout, S. L. (2018). Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors. Oncotarget, 9, 13796-13806. https://doi.org/10.18632/oncotarget.24488"}, {"Citation": "Kosciuczuk, E. M., Saleiro, D., Kroczynska, B., Beauchamp, E. M., Eckerdt, F., Blyth, G. T., Abedin, S. M., Giles, F. J., Altman, J. K., & Platanias, L. C. (2016). Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo. Blood: American Society of Hematology, 128, 410-414. https://doi.org/10.1182/blood-2016-02-698704"}, {"Citation": "Kremeyer, B., Lopera, F., Cox, J. J., Momin, A., Rugiero, F., Marsh, S., Woods, C. G., Jones, N. G., Paterson, K. J., Fricker, F. R., & Villegas, A. (2010). A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron, 66, 671-680. https://doi.org/10.1016/j.neuron.2010.04.030"}, {"Citation": "Kuehl, F. A., Jr., & Egan, R. W. (1980). Prostaglandins, arachidonic acid, and inflammation. Science, 210, 978-984. https://doi.org/10.1126/science.6254151"}, {"Citation": "Kumar, M. R., Park, A., Park, N., & Lee, S. (2011). Consecutive condensation, C-N and N-N bond formations: A copper-catalyzed one-pot three-component synthesis of 2 H-indazole. Organic Letters, 13, 3542-3545. https://doi.org/10.1021/ol201409j"}, {"Citation": "Lee, F. Y., Lien, J. C., Huang, L. J., Huang, T. M., Tsai, S. C., Teng, C. M., Wu, C. C., Cheng, F. C., & Kuo, S. C. (2001). Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl) indazole analogues as novel antiplatelet agents. Journal of Medicinal Chemistry, 44, 3746-3749. https://doi.org/10.1021/jm010001h"}, {"Citation": "Lee, K. Y., Gowrisankar, S., & Kim, J. N. (2005). Facile synthesis of 2H-indazole derivatives starting from the Baylis-Hillman adducts of 2-cyclohexen-1-one. Tetrahedron Letters, 46, 5387-5591. https://doi.org/10.1016/j.tetlet.2005.05.149"}, {"Citation": "Lee, S. J., Kim, Y. J., Lee, C. S., & Bae, J. (2009). Combined application of camptothecin and the guanylate cyclase activator YC-1: Impact on cell death and apoptosis-related proteins in ovarian carcinoma cell lines. Chemico-Biological Interactions, 181, 185-192. https://doi.org/10.1016/j.cbi.2009.05.013"}, {"Citation": "Lehmann, F., Koolmeister, T., Odell, L. R., & Scobie, M. (2009). A versatile new synthetic route to 1 N-hydroxyindazoles. Organic Letters, 11, 5078-5081. https://doi.org/10.1021/ol902085k"}, {"Citation": "Li, P., Zhao, J., Wu, C., Larock, R. C., & Shi, F. (2011). Synthesis of 3-substituted indazoles from arynes and N-tosylhydrazones. Organic Letters, 13, 3340-3343. https://doi.org/10.1021/ol201086g"}, {"Citation": "Li, P., Wu, C., Zhao, J., Rogness, D. C., & Shi, F. (2012). Synthesis of substituted 1H-indazoles\u00a0from arynes and hydrazines. Journal of Organic Chemistry, 77, 3149-3158. https://doi.org/10.1021/jo202598e"}, {"Citation": "Lien, J. C., Lee, F. Y., Huang, L. J., Pan, S. L., Guh, J. H., Teng, C. M., & Kuo, S. C. (2002). 1-Benzyl-3-(5 \u2018-hydroxymethyl-2 \u2018-furyl) indazole (YC-1) derivatives as novel inhibitors against sodium nitroprusside-induced apoptosis. Journal of Medicinal Chemistry, 45, 4947-4949. https://doi.org/10.1021/jm020070b"}, {"Citation": "Liu, D., Offin, M., Harnicar, S., Li, B. T., & Drilon, A. (2018). Entrectinib: An orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors. Therapeutics and Clinical Risk Management, 14, 1247. https://doi.org/10.2147/TCRM.S147381"}, {"Citation": "Liu, J., Peng, X., Dai, Y., Zhang, W., Ren, S., Ai, J., Geng, M., & Li, Y. (2015). Design, synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold. Organic and Biomolecular Chemistry, 13, 7643-7654. https://doi.org/10.1039/c5ob00778j"}, {"Citation": "Liu, Q., Yan, H., Zheng, X., Fu, L., Bao, Y., Zheng, H., Liu, Z., Zhang, X., & Chen, G. (2021). A novel indazole derivative, compound Cyy-272, attenuates LPS-induced acute lung injury by inhibiting JNK phosphorylation. Toxicology and Applied Pharmacology, 1, 115648. https://doi.org/10.1016/j.taap.2021.115648"}, {"Citation": "Liu, Y. M., Jiang, Y. H., Liu, Q. H., & Chen, B. Q. (2013). Indazole-type alkaloids from the seeds of Nigella glandulifera. Phytochemistry Letters, 6, 556-559. https://doi.org/10.1016/j.phytol.2013.07.002"}, {"Citation": "Locke, K. W., Dunn, R. W., Hubbard, J. W., Vanselous, C. L., Cornfeldt, M., Fielding, S., & Strupczewski, J. T. (1990). HP 818: A centrally acting analgesic with neuroleptic properties. Drug Development Research, 19, 239-256. https://doi.org/10.1002/ddr.430190304"}, {"Citation": "Long, Z., Wang, Z., Zhou, D., Wan, D., & You, J. (2017). Rh (III)-Catalyzed regio-and chemoselective [4+ 1]-annulation of azoxy compounds with diazoesters for the synthesis of 2 H-indazoles: Roles of the azoxy oxygen atom. Organic Letters, 19, 2777-2780. https://doi.org/10.1021/acs.orglett.7b00631"}, {"Citation": "Lu, M., Felock, P. J., Munshi, V., Hrin, R. C., Wang, Y. J., Yan, Y., Munshi, S., McGaughey, G. B., Gomez, R., Anthony, N. J., & Williams, T. M. (2012). Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor. Antimicrobial Agents and Chemotherapy, 56, 3324-3335. https://doi.org/10.1128/aac.00102-12"}, {"Citation": "Lu, Z. H., & Kang, X. Q. (2019). Effectiveness of advanced nursing care on depression in patients with ovarian cancer: A protocol of systematic review of randomized controlled trial. Medicine, 98(17), e15316. https://doi.org/10.1097/md.0000000000015316"}, {"Citation": "Lukin, K., Hsu, M. C., Fernando, D., & Leanna, M. R. (2006). New practical synthesis of indazoles via condensation of O-fluorobenzaldehydes and their O-methyloximes with hydrazine. Journal of Organic Chemistry, 71, 8166-8172. https://doi.org/10.1021/jo0613784"}, {"Citation": "Luszczak, S., Kumar, C., Sathyadevan, V. K., Simpson, B. S., Gately, K. A., Whitaker, H. C., & Heavey, S. (2020). PIM kinase inhibition: Co-targeted therapeutic approaches in prostate cancer. Signal Transduction and Targeted Therapy, 5, 1-10. https://doi.org/10.1038/s41392-020-0109-y"}, {"Citation": "Malik, S., Hasan, S. S., Choudhary, M. I., Ni, C. Z., & Clardy, J. (1995). Nigellidine-A new indazole alkaloid from the seeds of Nigella sativa. Tetrahedron Letters, 36, 1993-1996. https://doi.org/10.1016/0040-4039(95)00210-4"}, {"Citation": "Modi, S. J., & Kulkarni, V. M. (2019). Vascular endothelial growth factor receptor (VEGFR-2)/KDR inhibitors: medicinal chemistry perspective. Medicine in Drug Discovery, 2, 100009. https://doi.org/10.1016/j.medidd.2019.100009"}, {"Citation": "Mora, E., Guglielmotti, A., Biondi, G., & Sassone-Corsi, P. (2012). Bindarit: An anti-inflammatory small molecule that modulates the NFkB pathway. Cell Cycle, 11, 159-169. https://doi.org/10.4161/cc.11.1.18559"}, {"Citation": "Nasr, M. N., & Said, S. A. (2003). Novel 3, 3a, 4, 5, 6, 7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents. Archiv der Pharmazie, 336, 551-559. https://doi.org/10.1002/ardp.200300796"}, {"Citation": "Nath, K., Guo, L., Nancolas, B., Nelson, D. S., Shestov, A. A., Lee, S. C., Roman, J., Zhou, R., Leeper, D. B., Halestrap, A. P., & Blair, I. A. (2016). Mechanism of antineoplastic activity of lonidamine. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1866, 151-162. https://doi.org/10.1016/j.bbcan.2016.08.001"}, {"Citation": "Niu, Y., Zhou, L., Meng, L., Chen, S., Ma, C., Liu, Z., & Kang, W. (2020). Recent progress on chemical constituents and pharmacological effects of the genus Nigella. Evidence-based Complementary and Alternative Medicine, 2020, 6756835. https://doi.org/10.1155/2020/6756835"}, {"Citation": "Oh, H., Han, S., Pandey, A. K., Han, S. H., Mishra, N. K., Kim, S., Chun, R., Kim, H. S., Park, J., & Kim, I. S. (2018). Synthesis of (2 H)-Indazoles through Rh (III)-catalyzed annulation reaction of azobenzenes with sulfoxonium ylides. Journal of Organic Chemistry, 83, 4070-4077. https://doi.org/10.1021/acs.joc.8b00501"}, {"Citation": "Pal, D., Tripathi, R., Pandey, D. D., & Mishra, P. (2014). Synthesis, characterization, antimicrobial, and pharmacological evaluation of some 2, 5-disubstituted sulfonyl amino 1, 3, 4-oxadiazole and 2-amino-disubstituted 1, 3, 4-thiadiazole derivatives. Journal of Advanced Pharmaceutical Technology & Research, 5, 196-201. https://doi.org/10.4103/2231-4040.143040"}, {"Citation": "Palmer, M. H., & Kennedy, S. M. (1978). The electronic structure of heteroaromatic molecules; ab initio calculations and photoelectron spectra for the aza derivatives of benzo [c] furan, benzo [c] thiophen, N-methyl isoindole and related compounds. J. Mol. Structure, 43, 33-48. https://doi.org/10.1016/0022-2860(77)80021-5"}, {"Citation": "Paul, M. K., & Mukhopadhyay, A. K. (2004). Tyrosine kinase-Role and significance in cancer. International Journal of Medical Sciences, 1, 101-115. https://doi.org/10.7150/ijms.1.101"}, {"Citation": "Pazdur, R., Bready, B., Scalzo, A. J., Brandof, J. E., Close, D. R., Kolbye, S., & Winn, R. J. (1994). Phase II trial of piroxantrone in metastatic gastric adenocarcinoma. Investigational New Drugs, 12, 263-265. https://doi.org/10.1007/bf00873970"}, {"Citation": "P\u00e9rez-Villanueva, J., Y\u00e9pez-Mulia, L., Gonz\u00e1lez-S\u00e1nchez, I., Palacios-Espinosa, J. F., Soria-Arteche, O., Sainz-Espu\u00f1es, T. D., Cerb\u00f3n, M. A., Rodr\u00edguez-Villar, K., Rodr\u00edguez-Vicente, A. K., Cort\u00e9s-Gines, M., & Custodio-Galv\u00e1n, Z. (2017). Synthesis and biological evaluation of 2H-indazole derivatives: Towards antimicrobial and anti-inflammatory dual agents. Molecules, 22, 1864. https://doi.org/10.3390/molecules22111864"}, {"Citation": "Peruncheralathan, S., Khan, T. A., Ila, H., & Junjappa, H. (2004). \u03b1-Oxoketene dithioacetals mediated heteroaromatic annulation protocol for benzoheterocycles: An efficient regiocontrolled synthesis of highly substituted and annulated indazoles. Tetrahedron, 60, 3457-3464. https://doi.org/10.1016/j.tet.2004.02.029"}, {"Citation": "Prasad, A. N., & Reddy, B. M. (2013). Cascade synthesis of N-heterocyclic compounds through one-pot MCR over CuII\u2212hydrotalcite catalyst. Current Catalysis, 2, 159-172."}, {"Citation": "Pryde, D. C., Marron, B. E., West, C. W., Reister, S., Amato, G., Yoger, K., Antonio, B., Padilla, K., Cox, P. J., Turner, J., & Warmus, J. S. (2017). Discovery of a series of indazole TRPA1 antagonists. ACS Medicinal Chemistry Letters, 8, 666-671. https://doi.org/10.1021/acsmedchemlett.7b00140"}, {"Citation": "Puri, K. D., Doggett, T. A., Douangpanya, J., Hou, Y., Tino, W. T., Wilson, T., Graf, T., Clayton, E., Turner, M., Hayflick, J. S., & Diacovo, T. G. (2004). Mechanisms and implications of phosphoinositide 3-kinase \u03b4 in promoting neutrophil trafficking into inflamed tissue. Blood, 103, 3448-3456. https://doi.org/10.1182/blood-2003-05-1667"}, {"Citation": "Qian, S., He, T., Wang, W., He, Y., Zhang, M., Yang, L., Li, G., & Wang, Z. (2016). Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2, 3-dioxygenase 1 (IDO1) inhibition properties. Bioorganic and Medicinal Chemistry, 24, 6194-6205. https://doi.org/10.1016/j.bmc.2016.10.003"}, {"Citation": "Qin, J., Cheng, W., Duan, Y. T., Yang, H., & Yao, Y. (2021). Indazole as a privileged scaffold: The derivatives and their therapeutic applications. Anti-Cancer Agents in Medicinal Chemistry, 21, 839-860. https://doi.org/10.2174/1871520620999200818160350"}, {"Citation": "Rani, P., Pal, D., Hegde, R. R., & Hashim, S. R. (2014). Anticancer, anti-inflammatory, and analgesic activities of synthesized 2-(substituted phenoxy) acetamide derivatives. BioMed Research International, 2014, 386473. https://doi.org/10.1155/2014/386473"}, {"Citation": "Reddy, A. V., Gogireddy, S., & Dubey, P. K. (2015). Design, synthesis and characterization of 1 H-pyridin-4-yl-3, 5-disubstituted indazoles and their anti-inflammatory and analgesic activity. Journal of Chemical Sciences, 127, 433-438. https://doi.org/10.1007/s12039-015-0792-3"}, {"Citation": "Rini, B. I., Garrett, M., Poland, B., Dutcher, J. P., Rixe, O., Wilding, G., Stadler, W. M., Pithavala, Y. K., Kim, S., Tarazi, J., & Motzer, R. J. (2013). Axitinib in metastatic renal cell carcinoma: Results of a pharmacokinetic and pharmacodynamic analysis. Journal of Clinical Pharmacology, 53, 491-504. https://doi.org/10.1002/jcph.73"}, {"Citation": "Ripa, L., Edman, K., Dearman, M., Edenro, G., Hendrickx, R., Ullah, V., Chang, H. F., Lepist\u00f6, M., Chapman, D., Geschwindner, S., & Wissler, L. (2018). Discovery of a novel oral glucocorticoid receptor modulator (AZD9567) with improved side effect profile. Journal of Medicinal Chemistry, 61, 1785-1799. https://doi.org/10.1021/acs.jmedchem.7b01690"}, {"Citation": "Robichaux, J. P., Elamin, Y. Y., Tan, Z., Carter, B. W., Zhang, S., Liu, S., Li, S., Chen, T., Poteete, A., Estrada-Bernal, A., & Le, A. T. (2018). Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer. Nature Medicine, 24, 638-646. https://doi.org/10.1038/s41591-018-0007-9"}, {"Citation": "Rolfo, C., Ruiz, R., Giovannetti, E., Gil-Bazo, I., Russo, A., Passiglia, F., Giallombardo, M., Peeters, M., & Raez, L. (2015). Entrectinib: A potent new TRK, ROS1, and ALK inhibitor. Expert Opinion on Investigational Drugs, 24, 1493-1500. https://doi.org/10.1517/13543784.2015.1096344"}, {"Citation": "Rosati, O., Curini, M., Marcotullio, M. C., Macchiarulo, A., Perfumi, M., Mattioli, F. Rismondo, L., & Cravotto, G. (2007). Synthesis, docking studies and anti-inflammatory activity of 4, 5, 6, 7-tetrahydro-2H-indazole derivatives. Bioorganic and Medicinal Chemistry, 15, 3463-3473. https://doi.org/10.1016/j.bmc.2007.03.006"}, {"Citation": "Saczewski, F., Hudson, A. L., Tyacke, R. J., Nutt, D. J., Man, J., Tabin, P., & Saczewski, J. (2003). 2-(4, 5-Dihydro-1H-imidazol-2-yl) indazole (indazim) derivatives as selective I2 imidazoline receptor ligands. European Journal of Pharmaceutical Science, 20, 201-208. https://doi.org/10.1016/S0928-0987(03)00182-9"}, {"Citation": "Sahoo, C. R., Paidesetty, S. K., & Padhy, R. N. (2019). Norharmane as a potential chemical entity for development of anticancer drugs. European Journal of Medicinal Chemistry, 162, 752-764. https://doi.org/10.1016/j.ejmech.2018.11.024"}, {"Citation": "Sahoo, J., Sahoo, C. R., Sarangi, P. K., Prusty, S. K., Padhy, R. N., & Paidesetty, S. K. (2020). Molecules with versatile biological activities bearing antipyrinyl nucleus as pharmacophore. European Journal of Medicinal Chemistry, 186, 111911. https://doi.org/10.1016/j.ejmech.2019.111911"}, {"Citation": "Salim, S. A. (2018). Identification of active pharmaceutical ingredients in Thevetia neriifolia Juss Leaf Callus using analysis of GC-MS. Indian Journal of Public Health Research & Development, 9(12), 1019-1023. https://doi.org/10.5958/0976-5506.2018.01982.4"}, {"Citation": "Sandeep Reddy, G., Mohanty, S., Kumar, J., & Venteswar Rao, B. (2018). Synthesis and evaluation of anticancer activity of indazole derivatives. Russian Journal of General Chemistry, 88, 2394-2399. https://doi.org/10.1134/S1070363218110233"}, {"Citation": "Sartore-Bianchi, A., Pizzutilo, E. G., Marrapese, G., Tosi, F., Cerea, G., & Siena, S. (2020). Entrectinib for the treatment of metastatic NSCLC: Safety and efficacy. Expert Review of Anticancer Therapy, 20, 333-341. https://doi.org/10.1080/14737140.2020.1747439"}, {"Citation": "Sather, A. C., Berryman, O. B., & Rebek, J. (2012). Synthesis of fused indazole ring systems and application to nigeglanine hydrobromide. Organic Letters, 14, 1600-1603. https://doi.org/10.1021/ol300303s"}, {"Citation": "Schenone, S., Bruno, O., Ranise, A., Brullo, C., Bondavalli, F., Filippelli, W., Mazzeo, F., Capuano, A., & Falcone, G. (2003). 2-Aryl-3-phenylamino-4, 5-dihydro-2h-benz [g] indazoles with analgesic activity. Il Farmaco, 58, 845-849. https://doi.org/10.1016/S0014-827X(03)00142-3"}, {"Citation": "Schindler, R., Fleischhauer, I., H\u00f6fgen, N., Sauer, W., Egerland, U., Poppe, H., Heer, S., Szelenyi, I., Kutscher, B., & Engel, J. (1998). 1, 5-Disubstituted Indazol-3-ols with anti-inflammatory activity. Archiv der Pharmazie, 331, 13-21. https://doi.org/10.1002/(SICI)1521-4184(199801)331"}, {"Citation": "Schmidt, A., Merkel, L., & Eisfeld, W. (2005). Nucleophilic carbenes and pseudo-cross-conjugated mesomeric betaines of indazole starting from analogues of the alkaloid-betaine nigellicine. European Journal of Organic Chemistry, 2005(10), 2124-2130. https://doi.org/10.1002/ejoc.200500032"}, {"Citation": "Schmidt, A., Beutler, A., & Snovydovych, B. (2008). Recent advances in the chemistry of indazoles. European Journal of Organic Chemistry, 2008, 4073-4095. https://doi.org/10.1002/ejoc.200800227"}, {"Citation": "Schoene, J., Bel Abed, H., Schmieder, P., Christmann, M., & Nazar\u00e9, M. (2018). A general one-pot synthesis of 2H-Indazoles using an organophosphorus-silane system. Chemistry - A European Journal, 24, 9090-9100. https://doi.org/10.1002/chem.201800763"}, {"Citation": "Scott, L. J. (2017). Niraparib: First global approval. Drugs, 77, 1029-1034. https://doi.org/10.1007/s40265-017-0752-y"}, {"Citation": "Selwood, D. L., Brummell, D. G., Budworth, J., Burtin, G. E., Campbell, R. O., Chana, S. S., Charles, I. G., Fernandez, P. A., Glen, R. C., Goggin, M. C., & Hobbs, A. J. (2001). Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclase. Journal of Medicinal Chemistry, 44, 78-93. https://doi.org/10.1021/jm001034k"}, {"Citation": "Sengel-Turk, C. T., Alcigir, M. E., Ekim, O., Bakar-Ates, F., & Hascicek, C. (2020). Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft f\u00fcr Pharmazeutische Verfahrenstechnik e.V, 157, 211-220. https://doi.org/10.1016/j.ejpb.2020.10.016"}, {"Citation": "Solano, L. N., Nelson, G. L., Ronayne, C. T., Jonnalagadda, S., Jonnalagadda, S. K., Kottke, K., Chitren, R., Johnson, J. L., Pandey, M. K., Jonnalagadda, S. C., & Mereddy, V. R. (2020). Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents. Scientific Reports, 10, 1-10."}, {"Citation": "Song, J. J., & Yee, N. K. (2000). A novel synthesis of 2-aryl-2 H-indazoles via a palladium-catalyzed intramolecular amination reaction. Organic Letters, 2, 519-521. https://doi.org/10.1021/ol990409x"}, {"Citation": "Spiteri, C., Keeling, S., & Moses, J. E. (2010). New synthesis of 1-substituted-1 H-indazoles via 1, 3-dipolar cycloaddition of in situ generated nitrile imines and benzyne. Organic Letters, 12, 3368-3371. https://doi.org/10.1021/ol101150t"}, {"Citation": "Sun, F., Feng, X., Zhao, X., Huang, Z. B., & Shi, D. Q. (2012). An efficient synthesis of 2H-indazoles via reductive cyclization of 2-nitrobenzylamines induced by low-valent titanium reagent. Tetrahedron, 68, 3851-3855. https://doi.org/10.1016/j.tet.2012.03.043"}, {"Citation": "Sun, J. H., Teleha, C. A., Yan, J. S., Rodgers, J. D., & Nugiel, D. A. (1997). Efficient synthesis of 5-(bromomethyl)-and 5-(aminomethyl)-1-THP-indazole. Journal of Organic Chemistry, 62, 5627-5629. https://doi.org/10.1021/jo970375b"}, {"Citation": "Taher, A., Ladwa, S., Rajan, S. T., & Weaver, G. W. (2000). Synthesis of 2-aryl-2H-indazoles by base catalysed reaction of 2-nitrobenzyl triphenylphosphonium bromide and aryl isocyanates. Tetrahedron Letters, 41, 9893-9897. https://doi.org/10.1016/S0040-4039(00)01757-3"}, {"Citation": "Thangadurai, A., Minu, M., Wakode, S., Agrawal, S., & Narasimhan, B. (2012). Indazole: A medicinally important heterocyclic moiety. Medicinal Chemistry Research, 21, 1509-1523. https://doi.org/10.1007/s00044-011-9631-3"}, {"Citation": "Tiwari, S., Mehta, D., Mehta, B. K., & Kumar, P. (2017). Characterization and identification of novel volatile constituents in organic solvent extracts of Syzygium cumini (bark) by GC-MS. Journal of Chemical Sciences, 7, 1250-1256."}, {"Citation": "Tsujino, H., Uno, T., Yamashita, T., Katsuda, M., Takada, K., Saiki, T., Maeda, S., Takagi, A., Masuda, S., Kawano, Y., & Meguro, K. (2019). Correlation of indoleamine-2, 3-dioxigenase 1 inhibitory activity of 4, 6-disubstituted indazole derivatives and their heme binding affinity. Bioorganic & Medicinal Chemistry Letters, 29, 126607."}, {"Citation": "Tzanetou, E., Liekens, S., Kasiotis, K. M., Fokialakis, N., & Haroutounian, S. A. (2012). Novel pyrazole and indazole derivatives: Synthesis and evaluation of their anti-proliferative and anti-angiogenic activities. Archiv der Pharmazie, 345, 804-811. https://doi.org/10.1002/ardp.201200057"}, {"Citation": "Tzvetkov, N. T., Stammler, H. G., Neumann, B., Hristova, S., Antonov, L., & Gastreich, M. (2017). Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors. European Journal of Medicinal Chemistry, 127, 470-492. https://doi.org/10.1016/j.ejmech.2017.01.011"}, {"Citation": "Upward, J. W., Arnold, B. D., Link, C., Pierce, D. M., Allen, A., & Tasker, T. C. (1990). The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist. European Journal of Cancer, 26, S12-S15."}, {"Citation": "Urquhart, L. (2019). FDA new drug approvals in Q3 2019. Nature Reviews. Drug Discovery, 18, 816-817. https://doi.org/10.1038/d41573-019-00177-7"}, {"Citation": "Ushijima, K., Wake, N., Kobayashi, H., Hachisuga, T., Toki, N., Masuzaki, H., Kotera, K., Kawarabayashi, T., Emoto, M., & Kamura, T. (2008). The efficacy and safety of indisetron hydrochloride for the management of nausea/vomiting caused by chemotherapy for gynecologic cancer. Gan To Kagaku Ryoho [Japanese Journal of Cancer and Chemotherapy], 35, 1169-1173."}, {"Citation": "Wan, Y., He, S., Li, W., & Tang, Z. (2018). Indazole derivatives: Promising anti-tumor agents. Anti-Cancer Agents in Medicinal Chemistry, 18, 1228-1234. https://doi.org/10.2174/1871520618666180510113822"}, {"Citation": "Wan, Y., Li, Y., Yan, C., Wen, J., & Tang, Z. (2020). Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors. Bioorganic Chemistry, 104, 104217. https://doi.org/10.1016/j.bioorg.2020.104217"}, {"Citation": "Wang, H. L., Cee, V. J., Chavez, F., Jr., Lanman, B. A., Reed, A. B., Wu, B., Guerrero, N., Lipford, J. R., Sastri, C., Winston, J., & Andrews, K. L. (2015). The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors. Bioorganic & Medicinal Chemistry Letters, 25, 834-840. https://doi.org/10.1016/j.bmcl.2014.12.068"}, {"Citation": "Wei, W., Wang, Z., Yang, X., Yu, W., & Chang, J. (2017). Divergent synthesis of 1H-Indazoles and 1H-Pyrazoles from hydrazones via iodine-mediated intramolecular aryl and sp3 C-H amination. Advanced Synthesis & Catalysis, 359, 3378-3387. https://doi.org/10.1002/adsc.201700824"}, {"Citation": "Wei, W., Liu, Z., Wu, X., Gan, C., Su, X., Liu, H., Que, H., Zhang, Q., Xue, Q., Yue, L., & Yu, L. (2021). Synthesis and biological evaluation of indazole derivatives as anti-cancer agents. RSC Advances, 11, 15675-15687. https://doi.org/10.1039/D1RA01147B"}, {"Citation": "Wu, C., Fang, Y., Larock, R. C., & Shi, F. (2010). Synthesis of 2 H-Indazoles by the [3+ 2] cycloaddition of arynes and sydnones. Organic Letters, 12, 2234-2237. https://doi.org/10.1021/ol100586r"}, {"Citation": "Xavier, R. J., & Podolsky, D. K. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature, 448, 427-434. https://doi.org/10.1038/nature06005"}, {"Citation": "Yakaiah, T., Kurumurthy, C., Lingaiah, B. P., Narsaiah, B., Pamanji, R., Velatooru, L. R., Rao, J. V., Gururaj, S., Parthasarathy, T., & Sridhar, B. (2012). GdCl3 promoted synthesis of novel pyrimidine fused indazole derivatives and their anticancer activity. Medicinal Chemistry Research, 21, 4261-4273. https://doi.org/10.1007/s00044-011-9962-0"}, {"Citation": "Yang, J., Zhou, Q., Chen, H., Wu, L., Zhao, J., Guo, R., Fan, Y., Shi, H., Xue, W., Zhang, P., & Han, H. Z. (2020). Abstract CT127: A phase I study of cMET inhibitor bozitinib in patients with advanced NSCLC harboring cMET alterations. Cancer Research, 80, CT127. https://doi.org/10.1158/1538-7445.AM2020-CT127"}, {"Citation": "Yang, L., Chen, Y., He, J., Njoya, E. M., Chen, J., Liu, S., Xie, C., Huang, W., Wang, F., Wang, Z., & Li, Y. (2019). 4, 6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors. Bioorganic and Medicinal Chemistry, 27, 1087-1098. https://doi.org/10.1016/j.bmc.2019.02.014"}, {"Citation": "Yap, J. L., Chen, L., Lanning, M. E., & Fletcher, S. (2017). Expanding the cancer arsenal with targeted therapies: Disarmament of the antiapoptotic Bcl-2 proteins by small molecules: Miniperspective. Journal of Medicinal Chemistry, 60, 821-838. https://doi.org/10.1021/acs.jmedchem.5b01888"}, {"Citation": "Yeo, E. J., Chun, Y. S., Cho, Y. S., Kim, J., Lee, J. C., Kim, M. S., & Park, J. W. (2003). YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1. Journal of the National Cancer Institute, 95, 516-525. https://doi.org/10.1093/jnci/95.7.516"}, {"Citation": "Yi, X., Jiao, L., & Xi, C. (2016). I 2-Mediated 2 H-indazole synthesis via halogen-bond-assisted benzyl C-H functionalization. Organic and Biomolecular Chemistry, 14, 9912-9918. https://doi.org/10.1039/c6ob01827k"}, {"Citation": "Yuan, T., Nahar, P., Sharma, M., Liu, K., Slitt, A., Aisa, H. A., & Seeram, N. P. (2014). Indazole-type alkaloids from Nigella sativa seeds exhibit antihyperglycemic effects via AMPK activation in vitro. Journal of Natural Products, 77, 2316-2320. https://doi.org/10.1021/np500398m"}, {"Citation": "Zhang, Z., Huang, Y., Huang, G., Zhang, G., & Liu, Q. (2017). [Bis-(trifluoroacetoxy) iodo] benzene-mediated oxidative direct amination C-N bond formation: Synthesis of 1H-Indazoles. Journal of Heterocyclic Chemistry, 54, 2426-2433. https://doi.org/10.1002/jhet.2839"}, {"Citation": "Zhao, C. R., Wang, R. Q., Li, G., Xue, X. X., Sun, C. J., Qu, X. J., & Li, W. B. (2013). Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines. Bioorganic & Medicinal Chemistry Letters, 23, 1989-1992. https://doi.org/10.1016/j.bmcl.2013.02.034"}, {"Citation": "Zhu, X. Q., Mao, S., Guo, D. D., Li, B., Guo, S. H., Gao, Y. R., & Wang, Y. Q. (2017). Copper-catalyzed isomerization and cyclization of E/Z-o-Haloaryl N-Sulfonylhydrazones: Convenient access to 1H-Indazoles. ChemCatChem, 9, 1084-1091. https://doi.org/10.1002/cctc.201601243"}, {"Citation": "Zoja, C., Corna, D., Locatelli, M., Rottoli, D., Pezzotta, A., Morigi, M., Zanchi, C., Buelli, S., Guglielmotti, A., Perico, N., & Remuzzi, A. (2015). Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease. Nephron, 129, 52-61. https://doi.org/10.1159/000369149"}, {"Citation": "ZS, O., Ogunmola, O. O., Kuyooro, S. E., & Abiona, O. O. (2017). Stachytarpheta jamaicensis leaf extract: Chemical composition, antioxidant, anti-arthritic, anti-inflammatory and bactericidal potentials. Journal of Scientific\u00a0and\u00a0Innovative\u00a0Research, 6, 119-125."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2022", "Month": "7", "Day": "4"}, {"Year": "2022", "Month": "4", "Day": "23"}, {"Year": "2022", "Month": "7", "Day": "22"}, {"Year": "2022", "Month": "8", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "16", "Hour": "5", "Minute": "43"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35971890", "10.1002/ddr.21979"]}}], "PubmedBookArticle": []}